Louis Plamondon

This inventor holds 28 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 5 EPO patents, primarily in Tetracycline Compounds. Top assignees: Millennium Pharmaceuticals Limited, Tetraphase Pharmaceuticals, Inc., Proscript, Inc.. Active years: 1998-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Louis Plamondon. Retrieved from https://idiyas.com/inventor/louis-plamondon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 7)

% Patents Active = 71.4

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 5.5

ph-index = 16

Forward Citations = 1,186(Granted Patents)

Location History:

Cambridge, MA (US) (2000)
Watertown, MA (US) (2000 - 2006)
Belmont, MA (US) (1998 - 2017)
Montreal, CA (2014 - 2018)

Company Filing History:

15 out of 854

Millennium Pharmaceuticals Limited

patents

9 out of 18

Tetraphase Pharmaceuticals, Inc.

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

6. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2018

Loading Chart...

Areas of Expertise:

Tetracycline Compounds

Boronic Ester Compounds

Synthesis

Fluoro Substituted

8-AZA Compounds

Polycyclic Compounds

Clasto-Lactacystin

Beta-Lactone

Treatment of Infarcts

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10072007 - Tetracycline compounds (2018-09-11),

2. 9624166 - Tetracycline compounds (2017-04-18),

3. 9371283 - Polycyclic tetracycline compounds (2016-06-21),

4. 9315451 - Tetracycline compounds (2016-04-19),

5. 8906887 - C7-fluoro substituted tetracycline compounds (2014-12-09),

6. 8828988 - 8-AZA tetracycline compounds (2014-09-09),

7. 8796245 - C7-fluoro substituted tetracycline compounds (2014-08-05),

8. 8501716 - C7-fluoro substituted tetracycline compounds (2013-08-06),

9. 8378099 - Boronic ester and acid compounds, synthesis and uses (2013-02-19),

10. 8367654 - 8-AZA tetracycline compounds (2013-02-05),

11. 8003791 - Boronic ester and acid compounds, synthesis and uses (2011-08-23),

12. 7531526 - Boronic ester and acid compounds, synthesis and uses (2009-05-12),

13. 7119080 - Boronic ester and acid compounds, synthesis and uses (2006-10-10),

14. 7109323 - Formulation of boronic acid compounds (2006-09-19),

15. 6794516 - Synthesis of clasto-lactacystin &bgr;-lactone and analogs thereof (2004-09-21),

Title: **The Innovative Contributions of Louis Plamondon**

Introduction

Louis Plamondon is a notable inventor based in Belmont, MA, USA, recognized for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 28 patents, he has demonstrated a commitment to advancing medical science through innovative solutions.

Latest Patents

Among his most recent inventions are several patents related to tetracycline compounds. One specific patent focuses on a compound represented by a specific structural formula and includes details about pharmaceutically acceptable salts. This patent encompasses a pharmaceutical composition that contains the compound and outlines its therapeutic uses. Such developments indicate his dedication to enhancing treatment options available in modern medicine.

Career Highlights

Throughout his career, Louis Plamondon has made notable contributions while working at well-respected companies such as Millennium Pharmaceuticals Limited and Tetraphase Pharmaceuticals, Inc. His work in these organizations has allowed him to leverage his innovative ideas in practical applications, benefiting the pharmaceutical industry significantly.

Collaborations

Collaboration is essential in the field of innovation, and Louis has worked alongside distinguished colleagues, including Julian Adams and Louis Grenier. These partnerships have fostered creativity and supported the development of impactful inventions within the pharmaceutical domain.

Conclusion

In summary, Louis Plamondon represents the spirit of innovation through his extensive patent work and collaborations in the pharmaceutical industry. His contributions, especially in the area of tetracycline compounds, highlight the ongoing efforts to improve healthcare solutions and showcase the vital role of inventors in driving progress in science and technology.

Profile summary based on public USPTO records.